In vivo experiments showed that both IFN-γ-Exo and Ctrl-Exo could down-regulate the expression of BTG2 in myocardial tissue after infarction, and IFN-γ-Exo had a better inhibitory effect (Additional file 1: Fig. S1C–D). The gene discussed is BTG2; the disease is infarction.